Events
On November 28, 2018, PCT Europe announced to its attendees that the Society for Clinical Research Sites’ late founder, Christine Pierre, was awarded the 2018 Lifetime Achievement Award.
Prof. Dr. Helga Rübsamen-Schaeff, Founding-CEO, and Dr. Holger Zimmermann, CEO of AiCuris Anti-Infective Cures GmbH, were awarded the German Future Prize 2018 (German President’s Award for Innovation in Science and Technology) presented by the German Federal President, Frank-Walter Steinmeier
Retrophin, Inc. today announced that Stephen Aselage, chief executive officer, will present at the BMO 2018 Prescriptions for Success Healthcare Conference in New York City on Wednesday, December 12, 2018 at 9:20 a.m. ET.
Digital Health Startups Encouraged to Apply for New Orleans Health Innovators Challenge
Prof. Dr. Helga Rübsamen-Schaeff, Founding-CEO, and Dr. Holger Zimmermann, CEO of AiCuris Anti-Infective Cures GmbH, were awarded the German Future Prize 2018 (German President’s Award for Innovation in Science and Technology) presented by the German Federal President, Frank-Walter Steinmeier
The American Society of Hematology is holding its 60th Annual Meeting & Exposition starting December 1 and running through December 4 in San Diego. Most of the players, big and small, in cancer drug therapies will be there, presenting updates and breaking stories about their hematology pipelines.
Francis Collins, director of the National Institutes of Health (NIH) and the scientist who led the Human Genome Project, weighed in on the recent case of He Jiankui.
Voice is showing great promise to drive radical transformation in healthcare. In pharmacy and biotech, conversational interfaces are now used to support “virtual trials” with newfound opportunities to automate a trial’s plethora of resource-intensive processes.
We thought it would be insightful to look back at our previous lists to see where some of those companies are today. Here’s a look at the top 3 companies from the Top 20 Life Science Startups to Watch in the U.S. from 2017.
Ellex Medical Lasers Limited (ASX:ELX), a global leader in medical devices for the diagnosis and treatment of eye disease, today reported its sales for the 4 months to 31 October 2018 to shareholders at the Company Annual General Meeting.
PRESS RELEASES